Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MTS (Daytrana) in adolescents with ADHD
NCT00499863Phase 3Completed
- Sponsor
- Noven Therapeutics, LLC
- Start
- Jul 2007
- Primary completion
- May 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of methylphenidate transdermal system in attention deficit hyperactivity disorder (ADHD), sponsored by Noven Therapeutics, LLC. Started Jul 2007; status: completed.
02
Drugs
methylphenidate transdermal system
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT00499863.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00499863.